Kyrgyzstan IVF 2026 New Policy: Eligible Groups, Process & Conditions Explained

========== AI Summary ==========

Policy Analysis · Practitioner Perspective

Policy Adjustment Background and Core Changes

At the end of 2025, the Ministry of Health of Kyrgyzstan issued the "Regulations on the Management of Assisted Reproductive Technology (2026 Revision)" (hereinafter referred to as the "New Regulations"), systematically updating the institutions, personnel, indications, and operational procedures for in vitro fertilization-embryo transfer and related derivative technologies within the country. This is the most significant adjustment since the country first legislated to regulate assisted reproduction in 2018.

The core changes of the new regulations focus on four dimensions: Eligible Group Boundaries, PGT Technology Access, Embryo In Vitro Culture Time Limit, and Management of Foreign Patients. These are broken down one by one below.

Expanded Eligible Groups PGT Access Embryo Culture 14 Days Medical Visa Requirement Surrogacy Ban

Eligible Groups: Who Meets the New Regulations' Conditions

The new regulations have changed the description of eligible groups from "legally married couples medically diagnosed with infertility" to the following three categories:

• Married Infertile Couples: Must provide medical records of at least 12 months of unprotected intercourse without pregnancy, or a clear diagnosis of a disease affecting fertility (e.g., bilateral tubal blockage, severe oligoasthenospermia, ovulation disorders, etc.).
• Carriers of Specific Genetic Diseases: Individuals confirmed through genetic counseling to have a monogenic disease or chromosomal structural abnormality that can be blocked via PGT technology, regardless of marital status.
• Single Women (Requiring Additional Evaluation): Single women legally residing in Kyrgyzstan or holding a long-term residence permit must undergo a psychological evaluation and ethics committee approval, and must be no older than 45 years of age.

From a practical implementation standpoint, foreign single women currently cannot directly apply for IVF for "non-medical reasons" unless they also meet the criteria for genetic disease indications. This point is easily misunderstood during consultations and requires special attention.

Technology Access: PGT and Embryo Culture New Regulations

The two most notable technological changes in the 2026 new regulations are:

Official Access to PGT Technology

Previously, Kyrgyzstan only allowed morphological assessment of embryos and prohibited any form of genetic screening. The new regulations specify that institutions meeting the following conditions can apply to carry out PGT:

• Possess an independent genetics laboratory and be equipped with at least one clinical geneticist;
• The embryology laboratory must be ISO 15189 certified or meet equivalent international standards;
• Complete at least 200 IVF cycles annually, with a clinical pregnancy rate not lower than 40%.

This means not all reproductive centers can offer PGT services. When choosing an institution, patients need to verify whether it has the qualifications required by the new regulations.

Embryo Culture Time Limit Extended to 14 Days

The old regulations stipulated that embryo in vitro culture must not exceed 7 days (i.e., only culturing to the blastocyst stage). The new regulations relax the upper limit to 14 days, aiming to allow sufficient time for PGT testing and to support in-depth research on embryo developmental potential. However, note that:

• Culture exceeding 7 days is considered "extended culture" and requires the patient to sign a specific informed consent form;
• After 14 days, regardless of the embryo's status, culture must be terminated or the embryo must be frozen; further in vitro development is not allowed;
• Currently, no more than 3 laboratories in Kyrgyzstan can stably support 14-day culture.

Process and Documents: Application Steps and Document Requirements

According to the new regulations, the standard process for completing an IVF cycle in Kyrgyzstan is as follows:

Cost Breakdown: Factors Affecting Total Treatment Cost

The 2026 new regulations do not directly control the fee structure, but changes in technology access will indirectly affect expenses. Main cost items include:

• Basic IVF Cycle: Approximately $7,000 to $12,000 USD (including stimulation medications, egg retrieval, embryo culture, transfer);
• PGT Testing: Approximately $1,500 to $2,500 USD per embryo, varying by testing scope (FISH / aCGH / NGS);
• Extended Culture Fee: An additional $200 to $400 USD per day for culture exceeding 7 days;
• Document and Administrative Fees: Medical invitation letter, visa, translation, notarization, etc., approximately $500 to $1,000 USD;
• Other: Freezing fee $600 to $1,000 USD per year, genetic counseling fee $300 to $600 USD.

Compared to Kazakhstan, cycle costs in Kyrgyzstan are about 15% to 20% lower, but PGT testing costs are similar. When choosing, one should not only look at the cycle price but also evaluate the laboratory quality and policy compatibility.

Comparison with Neighboring Country Policies

To facilitate decision-making, the following table compares key policy points for 2026 in Kyrgyzstan, Kazakhstan, and Uzbekistan:

In terms of policy openness, Kyrgyzstan has taken a middle path regarding PGT and IVF for single women, being neither as restrictive as Kazakhstan's complete ban on single women nor as conservative as Uzbekistan. However, for patients needing PGT, Kazakhstan offers a wider range of choices.

Practitioner Observations: Impact of New Regulations on Actual Treatment

In the months following the implementation of the new regulations, several phenomena at the practical level are worth noting:

• Strict PGT Qualification Review: As of Q1 2026, only 2 reproductive centers have passed PGT qualification certification, with 3 others applying. This has led some patients to still need referrals or wait.
• Low Utilization Rate of 14-Day Culture: Most patients still opt for standard culture. Extended culture is mainly used for those needing PGT and with slower embryo development. The actual utilization rate is about 12%.
• Increased Applications from Single Women: However, the approval rate is about 45%, mainly hindered by psychological evaluation and ethics committee approval stages. It is recommended to prepare a psychological evaluation report (in English or Russian) in advance.
• Stable Medical Visa Approval Rate for Foreign Patients: As long as documents are complete (especially the invitation letter and proof of funds), the approval rate is over 95%. The main reason for rejection is a passport validity of less than 18 months.

Frequently Asked Questions

Q1: Can I still do IVF in Kyrgyzstan with low AMH?

Yes. The new regulations do not list AMH as an exclusion criterion. However, the doctor will comprehensively assess ovarian response based on AMH, FSH, and AFC to create an individualized stimulation protocol. When AMH is below 0.5 ng/mL, the number of eggs retrieved may be lower, but cycle initiation is still possible. It is necessary to adjust expectations and discuss with the doctor whether a mild stimulation or natural cycle protocol is suitable.

Q2: How far in advance should I prepare for IVF in Kyrgyzstan?

From the initial consultation to starting the cycle, it generally takes 6 to 10 weeks. Document preparation (notarization, visa, invitation letter) accounts for about 3 to 4 weeks, and medical tests (some may require retesting) account for about 2 weeks. If PGT or genetic counseling is involved, an additional 2 to 4 weeks should be added.

Q3: What are the required tests for the male partner?

The new regulations require the male partner to provide at least: semen analysis (2 times), infectious disease screening (HIV, Hepatitis B, Hepatitis C, Syphilis), and chromosome karyotype analysis. If semen parameters are abnormal, Y-chromosome microdeletion testing is also required. These tests can be done in Kyrgyzstan or at a top-tier hospital in the home country, but reports must be translated and notarized.

Q4: What are the specific passport validity requirements?

The new regulations specify that the passport validity for foreign patients must exceed the planned stay in Kyrgyzstan by at least 18 months. For example, if planning to stay for 1 month, the remaining passport validity must be ≥ 19 months. If the validity is insufficient, it is recommended to renew the passport before starting the process, otherwise the medical visa may be rejected.

Q5: What are the "hidden thresholds" under the new regulations?

There are two easily overlooked points: First, all foreign patients must purchase medical insurance covering assisted reproductive treatment within Kyrgyzstan (with a minimum coverage of $50,000 USD). Second, if using donor eggs or sperm, the donor must be a Kyrgyz citizen or legal long-term resident, and matching must be done through a sperm bank or egg bank designated by the Ministry of Health; private donations are not allowed.

Handling Special Cases

For individuals with a history of recurrent implantation failure, recurrent miscarriage, or advanced age (≥ 40 years), the new regulations do not establish a separate channel, but doctors typically recommend:

• Completing a hysteroscopy evaluation and endometrial microbiome testing (ERA/EMT);
• Adding PGT testing to exclude embryonic aneuploidy;
• Considering the use of donor eggs (subject to the new regulations' donor management requirements).

It is important to note that the waiting time for donor eggs is uncertain, as the egg bank in Kyrgyzstan is relatively small, and matching may take 3 to 6 months. This is not a "fast track" and requires advance planning.

Summary and Timeline Planning Reminder

Kyrgyzstan's 2026 new policy represents a substantial step forward in technology access and eligible groups, particularly offering new options for genetic disease carriers and eligible single women. However, during the initial implementation phase, institutional qualifications, process衔接, and genetic counseling support are still being refined.

If you plan to travel to Kyrgyzstan for IVF treatment in 2026, it is recommended to follow this timeline:

• 3 to 4 months in advance: Complete all medical tests (AMH, FSH, semen analysis, chromosomes, etc.), ensure passport validity meets requirements, and prepare marriage certificate notarization;
• 2 to 3 months in advance: Contact the institution to obtain the invitation letter, submit the medical visa application, and simultaneously schedule the first in-person consultation;
• 1 month in advance: Confirm insurance purchase, arrange accommodation and travel, and complete the psychological evaluation (if applicable);
• After entering the country: Follow the doctor's protocol to start the cycle, paying attention to the documents required for the 14-day culture window.